title: The importance of a postpartum 75 g oral glucose tolerance test in women with gestational diabetes.
abstract: OBJECTIVE
  To compare the ability of the fasting plasma glucose (FPG) level with the ability of the 2-hour oral glucose tolerance test (OGTT) to identify women with any form of glucose intolerance within the first six postpartum months.
  
  
  METHODS
  In a retrospective, observational analysis, the predictive ability of the FPG level was compared with that of the 2-hour OGTT in 275 women followed for gestational diabetes who returned for postpartum testing.
  
  
  RESULTS
  With use of the FPG level alone, 4.4% of the women were found to have an FPG 7.0 mmol/L, identifying diabetes mellitus (DM); 2.5% had an FPG in the range 6.1-6.9 mmol/L, identifying impaired fasting glucose (IFG); and 93% had an FPG 6.0 mmol/L, i.e., within the normal range. Using the 2-hour 75g OGTT, 5% of women were found to have either an FPG 7.0 mmol/L or a 2-hour plasma glucose (PG) 11.1 mmol/L, identifying DM; 2.5% had an FPG of 6.1-6.9 mmol/L, identifying IFG; and 32% had a 2-hour PG of 7.8-11.0 mmol/L, identifying impaired glucose tolerance (IGT). Of the women with any glucose abnormality postpartum, an FPG level alone detected 15.8%, the post-glucose load level detected 97.5%, and an OGTT detected 100% of the women. An FPG level alone in 39% of cases failed to detect either IGT or DM and in 54% of cases, type 2 DM.
  
  
  CONCLUSIONS
  In view of the potential for early, effective prevention of DM, the optimal method for detecting glucose abnormalities in women within six months post partum is a 2-hour OGTT.
authors.affiliation: Department of Obstetrics and Gynecology, Royal Victoria Hospital, Montreal QC.
authors.forename: Shauna L
authors.initials: SL
authors.lastname: Reinblatt
authors.affiliation: Department of Obstetrics and Gynecology, Royal Victoria Hospital, Montreal QC.
authors.forename: Lucie
authors.initials: L
authors.lastname: Morin
authors.affiliation: Department of Obstetrics and Gynecology, Royal Victoria Hospital, Montreal QC; Department of Medicine, Division of Endocrinology, Royal Victoria Hospital, Montreal QC.
authors.forename: Sara J
authors.initials: SJ
authors.lastname: Meltzer
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis*; D016640:Diabetes, Gestational; D005260:Female; D005500:Follow-Up Studies; D018149:Glucose Intolerance / Q000097:blood / Q000175:diagnosis*; D005951:Glucose Tolerance Test; D006801:Humans; D049590:Postpartum Period / Q000097:blood / Q000378:metabolism; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
chemical_list: D001786:Blood Glucose